These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10227648)

  • 1. Intranasal sumatriptan for the acute treatment of migraine in children.
    Ueberall MA; Wenzel D
    Neurology; 1999 Apr; 52(7):1507-10. PubMed ID: 10227648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.
    Winner P; Rothner AD; Saper J; Nett R; Asgharnejad M; Laurenza A; Austin R; Peykamian M
    Pediatrics; 2000 Nov; 106(5):989-97. PubMed ID: 11061765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
    Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
    Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E; Salonen R; Saiers J; Woessner M
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?
    Hämäläinen ML; Hoppu K; Santavuori P
    Neurology; 1997 Apr; 48(4):1100-3. PubMed ID: 9109909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.
    Ahonen K; Hämäläinen ML; Rantala H; Hoppu K
    Neurology; 2004 Mar; 62(6):883-7. PubMed ID: 15037686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group.
    Salonen R; Ashford E; Dahlöf C; Dawson R; Gilhus NE; Lüben V; Noronha D; Warter JM
    J Neurol; 1994 Jul; 241(8):463-9. PubMed ID: 7964913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study.
    Fujita M; Sato K; Nishioka H; Sakai F
    Cephalalgia; 2014 Apr; 34(5):365-75. PubMed ID: 24163282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.
    Menshawy A; Ahmed H; Ismail A; Abushouk AI; Ghanem E; Pallanti R; Negida A
    Neurol Sci; 2018 Jan; 39(1):31-44. PubMed ID: 28942578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J; Bertin L; Pilgrim AJ; Ashford E; Bès A
    Neurology; 1996 Aug; 47(2):361-5. PubMed ID: 8757005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine.
    Wang SJ; Fuh JL; Wu ZA
    J Chin Med Assoc; 2007 Feb; 70(2):39-46. PubMed ID: 17339143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.